4zwv: Difference between revisions
No edit summary |
No edit summary |
||
Line 3: | Line 3: | ||
<StructureSection load='4zwv' size='340' side='right'caption='[[4zwv]], [[Resolution|resolution]] 1.50Å' scene=''> | <StructureSection load='4zwv' size='340' side='right'caption='[[4zwv]], [[Resolution|resolution]] 1.50Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[4zwv]] is a 2 chain structure with sequence from [ | <table><tr><td colspan='2'>[[4zwv]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Actinomadura_melliaura Actinomadura melliaura]. This structure supersedes the now removed PDB entry [http://oca.weizmann.ac.il/oca-bin/send-pdb?obs=1&id=4rxk 4rxk]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4ZWV OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4ZWV FirstGlance]. <br> | ||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=LLP:(2S)-2-AMINO-6-[[3-HYDROXY-2-METHYL-5-(PHOSPHONOOXYMETHYL)PYRIDIN-4-YL]METHYLIDENEAMINO]HEXANOIC+ACID'>LLP</scene>, <scene name='pdbligand=MSE:SELENOMETHIONINE'>MSE</scene></td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4zwv FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4zwv OCA], [https://pdbe.org/4zwv PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4zwv RCSB], [https://www.ebi.ac.uk/pdbsum/4zwv PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4zwv ProSAT]</span></td></tr> | |||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | |||
</table> | </table> | ||
== Function == | |||
[https://www.uniprot.org/uniprot/Q0H2X1_9ACTN Q0H2X1_9ACTN] | |||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Line 24: | Line 24: | ||
[[Category: Actinomadura melliaura]] | [[Category: Actinomadura melliaura]] | ||
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
[[Category: Bigelow | [[Category: Bigelow L]] | ||
[[Category: Endres | [[Category: Endres M]] | ||
[[Category: Joachimiak | [[Category: Joachimiak A]] | ||
[[Category: Kim | [[Category: Kim Y]] | ||
[[Category: Phillips Jr GN]] | |||
[[Category: Wang F]] | |||
[[Category: Phillips | |||
[[Category: Wang | |||
Latest revision as of 10:44, 18 May 2023
Crystal Structure of Aminotransferase AtmS13 from Actinomadura melliauraCrystal Structure of Aminotransferase AtmS13 from Actinomadura melliaura
Structural highlights
FunctionPublication Abstract from PubMedAT2433 from Actinomadura melliaura is an indolocarbazole antitumor antibiotic structurally distinguished by its unique aminodideoxypentose-containing disaccharide moiety. The corresponding sugar nucleotide-based biosynthetic pathway for this unusual sugar derives from comparative genomics where AtmS13 has been suggested as the contributing sugar aminotransferase (SAT). Determination of the AtmS13 X-ray structure at 1.50 A resolution reveals it as a member of the aspartate aminotransferase fold type I (AAT-I). Structural comparisons of AtmS13 with homologous SATs that act upon similar substrates implicate potential active site residues that contribute to distinctions in sugar C5 (hexose versus pentose) and/or sugar C2 (deoxy versus hydroxyl) substrate specificity. This article is protected by copyright. All rights reserved. Structural characterization of AtmS13, a putative sugar aminotransferase involved in indolocarbazole AT2433 aminopentose biosynthesis.,Singh S, Kim Y, Wang F, Bigelow L, Endres M, Kharel MK, Babnigg G, Bingman CA, Joachimiak A, Thorson JS, Phillips GN Proteins. 2015 Jun 9. doi: 10.1002/prot.24844. PMID:26061967[1] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. References
|
|